-
Two foreign companies "marriage" in Shanghai to produce high-end medical equipment.
Time of Update: 2020-09-30
on September 22nd, will cooperate in the production of ultra-high definition endoscope camera system. "marriage" between two foreign companies in China will boost the local production of this high-end medical device. this "marriage
-
And platinum medicine at the 2020 Cell Engager Summit to showcase the newly developed BCMA x CD3 dual-specific antibodies.
Time of Update: 2020-09-29
(HCAb-based dual-specific cell bridger) platform research and development, with efficient tumor killing and can reduce the release of cytokines, can reduce the risk of clinical cytokine storm side effects, can be converted into more effective and safe
-
India's first allogeneic cell product Stempeucel has been approved for sale!
Time of Update: 2020-09-28
Stempeutics has spent 12 years developing Stempeucel® a breakthrough stem cell therapy that provides an efficient production process that enables patients to access treatment products that address the root causes of the disease at an affordable cost.
-
It's too hard... HKT confirmed for the first time that a recovered person was second infected with the new coronavirus.
Time of Update: 2020-09-28
genealogies, with a total of 24 nucleotides, and found differences in amino acids on nine proteins, including hedgehogs and nucleoproteins. , the patient returned to Hong Kong for a second confirmed infection and was admitted to hospital, the body
-
Missed the main destination hundreds of mesquite treasure Idhifa combination therapy treatment leukemia trial failed.
Time of Update: 2020-09-27
, BMS announced the failure of Idhifa's phase III trial IDHENTIFY for acute myeloid leukemia, which failed to significantly improve the overall survival rate (OS) of patients.
-
350 jobs to be cut at Teva Israel plant in response to fierce generic competition.
Time of Update: 2020-09-27
we believe this process will restore the Neot-Havav plant to competitiveness and enable us to continue to increase the strategic focus of Israel's global activities in Teva.
-
TLC and Sansheng Pharmaceuticals have teamed up to launch antifellar products Chinese mainland.
Time of Update: 2020-09-27
TLC has authorized partner Sansheng Pharmaceuticals to be responsible for the commercialization ™ ampholipad Chinese mainland in the world.
-
48 new shares raised more than $11 billion! Under the outbreak, U.S. stocks biopharmaceutical IPO again boom.
Time of Update: 2020-09-26
New Crown vaccine developer CureVac listing: up 249% market value of nearly $10 billion 3.
-
Amjin PCSK9 inhibitor Repatha pediatric phase 3b study reached the main endpoint.
Time of Update: 2020-09-24
August 29, Amgen released positive data from a study of the cholesterol-lowering drug Repatha (Chinese commodity name: Rebean, common name: evolocumab, eloyu monoantigen) for the treatment of 10-17-year-old heterocyctic hypercholesterolemia (HeFH) pediatric patients.
-
Advance $20 million AstraZeneca expands its vaccine production partnership with Oxford Biomedica.
Time of Update: 2020-09-23
the cooperation time. , the agreement is for a period of three years, with an additional 18 months of retention in addition to the required 18-month supply period. as part of the agreement, Oxford Biomedica will retain capacity for AstraZeneca in three
-
Traditional health insurance is at the heart of the U.S. insurance market.
Time of Update: 2020-09-23
Medicine Network September 4th In the field of commercial health insurance, the United States is a group-based procurement of corporate insurance market, before the outbreak, the Number of U.S. employers paid for group insurance 163 million
-
NCCN's leading cancer treatment recommendations are now available Chinese edition.
Time of Update: 2020-09-23
NCCN's global team also offers patient-friendly translations in several languages, including Chinese, Japanese and Korean.
-
Bridgewest Australia Holdings LLC acquires Pfizer manufacturing facilities.
Time of Update: 2020-09-23
the Adelaide facility has manufacturing capabilities, staff expertise and support systems to manufacture and test microbial-based products at the cGMP (Dynamic Drug Production Management Practice) level, covering proteins, vaccines and protons from development to commercialization.
-
The world's top ten research and development institutions released, the Chinese Academy of Sciences ranked third, the United States accounted for 7 seats!
Time of Update: 2020-09-23
The National Institutes of Health (NIH), with nearly $40 billion in funding, is the most well-funded research and development institution in the United States, second only to Harvard University on this list.
-
Key findings from Novaral Tabrecta's treatment of patients with METex14 mutations have been published.
Time of Update: 2020-09-22
data show that Tabrecta's total response rate (ORR) was positive in adult patients with metastasis non-small cell lung cancer (NSCLC) mutations in the treatment of MET exon 14 jump (METex14) and positive for remission duration (DOR).
-
Concept Medical announced the use of MagicTouch Siromos-coated balloons to treat key Transform-1 randomized controlled trials of coronary artery small vascular lesions.
Time of Update: 2020-09-22
Read: Concept Medical Inc., which specializes in vascular interventional dosing devices, announced that transform-1 randomized controlled trials (treating coronary artery small vascular lesions: a randomized controlled trial for MagicTouch Siromos coated balloons) recruited the first patients.
-
Corning Jerry's double-specific antibody KN046 was awarded orphan drug status by the FDA.
Time of Update: 2020-09-22
includes: the adoption of CTLA-4 monolithic antibodies with significantly improved safety; and clinical trial results of KN046 show that they can significantly reduce possible toxic side effects on the human exodervirus system and are expected
-
The dynamics and new trends of AOL Healthcare.
Time of Update: 2020-09-19
to association of American Medical Colleges. as America's post-World War II population ages, a large number of doctors will retire and face a shortage of young doctors in the future. , telemedicies will help help remote, doctor-poor areas
-
Goodbye to the drug deposit!
Time of Update: 2020-09-11
", but also pay a high listing margin; With the opening of drug procurement authority in more and more cities and medical associations, assuming that different provinces or cities in the process of centralized procurement of drugs require suppliers
-
Research and development daily Roche published etrolizumab UC two maintenance therapy did not reach the end.
Time of Update: 2020-09-11
Coagulation pathway inhibitor therapy COVID-19 shows strong efficacy Omeros company recently announced the narsoplimab treatment of COVID-19 acute respiratory distress syndrome patients with a sympathetic drug results.
![4-Bromobenzo[b]thiophene 99%](https://acf-file.echemi.com/fileManage/upload/goodpicture/20191012/m20191012115043655.png)
